Christopher Jakubowski, MD @HopkinsMedicine #ASCO20 Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma

Christopher Jakubowski, MD @HopkinsMedicine #ASCO20 Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma

User Photo
Annual-Meeting

2 months
8 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Christopher Jakubowski, MD The Johns Hopkins discusses an abstract from The Journal of Clinical Oncology entitled Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma


Up Next Autoplay
>